Nanosonics Limited (ASX:NAN)
Australia · Delayed Price · Currency is AUD 3.460
+0.030 (0.87%)
At close: Mar 18, 2026
Nanosonics Market Cap
Nanosonics has a market cap or net worth of 1.04 billion as of March 18, 2026. Its market cap has decreased by -22.65% in one year.
Market Cap
1.04B
Enterprise Value
887.58M
Revenue
207.26M
Ranking
n/a
PE Ratio
52.03
Stock Price
3.46
Market Cap Chart
Since May 17, 2007, Nanosonics's market cap has increased from 151.14M to 1.04B, an increase of 588.58%. That is a compound annual growth rate of 10.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 1.04B | -13.58% |
| Dec 31, 2025 | 1.20B | 30.84% |
| Dec 31, 2024 | 920.45M | -30.92% |
| Dec 29, 2023 | 1.33B | 2.84% |
| Dec 30, 2022 | 1.30B | -31.96% |
| Dec 31, 2021 | 1.90B | -21.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 67.84B |
| Sigma Healthcare | 30.94B |
| Pro Medicus | 13.75B |
| Cochlear | 11.32B |
| Neuren Pharmaceuticals | 1.49B |
| PYC Therapeutics | 1.39B |
| Clarity Pharmaceuticals | 1.35B |
| Anteris Technologies Global | 884.81M |